Fiuza M, Pereirinha A, Carôla B, Pedro P, Dias E, Conduto R, Dionísio I, da Costa B B, Calçada L, Amador M da G
UCIM/Medicina IV, Hospital Universitário de Santa Maria, Faculdade de Medicina de Lisboa (FML).
Rev Port Cardiol. 1995 Dec;14(12):1007-17, 987.
Dobutamine stress echocardiography is a very promising technique for assessing myocardial viability, ischemia and prognosis in patients with a recent acute myocardial infarction. Recent studies have shown that the type of perfusion in the infarct-related artery also plays a role in the prognosis of these patients.
To evaluated in patients with non complicated infarction the ability of low-dose and high-dose dobutamine stress echocardiography to assess the presence of both viability and inducible ischemia and correlate the results with the patency of the infarct related artery and the accuracy to predict cardiac events during one year follow-up.
Fifty one consecutive in-hospital patients (47 male and four female, mean age 52 +/- 11 years, range 31-75 years) with acute myocardial infarction were evaluated both by dobutamine stress echocardiography and by coronary angiography and followed-up for a mean of 12 +/- 8 months.
With low-doses of dobutamine, the incidence of myocardial viability was 33% and with high-doses, the incidence of residual inducible ischemia was 41%. The patency of infarct-related artery showed significant correlation with score wall motion index for viability and for myocardial ischemia. Twenty four (47%) patients suffered cardiac events. Dobutamine stress echocardiography showed a positive predictive value of 67% and a negative of 70% and identified high and low risk patients.
Dobutamine stress echocardiography in patients with acute myocardial infarction is a safe and well tolerated test, and provides in a single test useful information regarding viability, ischemia and prognosis.
多巴酚丁胺负荷超声心动图是评估近期急性心肌梗死患者心肌存活性、缺血情况及预后的一项非常有前景的技术。近期研究表明,梗死相关动脉的灌注类型在这些患者的预后中也起作用。
评估非复杂性梗死患者中低剂量和高剂量多巴酚丁胺负荷超声心动图评估心肌存活性和诱发性缺血的能力,并将结果与梗死相关动脉的通畅情况相关联,以及预测一年随访期间心脏事件的准确性。
连续51例住院急性心肌梗死患者(47例男性,4例女性,平均年龄52±11岁,范围31 - 75岁)接受了多巴酚丁胺负荷超声心动图和冠状动脉造影评估,并进行了平均12±8个月的随访。
低剂量多巴酚丁胺时,心肌存活性发生率为33%;高剂量时,残余诱发性缺血发生率为41%。梗死相关动脉的通畅情况与存活心肌和心肌缺血的壁运动指数评分显著相关。24例(47%)患者发生心脏事件。多巴酚丁胺负荷超声心动图显示阳性预测值为67%,阴性预测值为70%,并识别出高危和低危患者。
急性心肌梗死患者的多巴酚丁胺负荷超声心动图是一项安全且耐受性良好的检查,并且在单次检查中可提供有关存活性、缺血情况及预后的有用信息。